People taking methotrexate for a variety of conditions have been warned by the NHS that a number of symptoms and side effects ...
Health and Me on MSN
Taking methotrexate for arthritis? Doctors explain the risks behind the latest warning
Methotrexate is widely prescribed for arthritis, psoriasis, and certain cancers. Here’s what patients need to know about ...
Biosimilar developers achieve key European approvals for denosumab and golimumab, enhancing patient access while facing US market entry delays.
NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable self-administration, automation in fill–finish ...
(RTTNews) - Celltrion Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO (omalizumab-igec)—the first and only biosimilar designated as ...
Schreiner MediPharm recently unveiled its new Cap-Lock Label with RFID functionality. The new Cap-Lock plus RFID is based on the proven principle of Schreiner MediPharm’s Cap-Lock Label and will be ...
Fresenius Kabi Simplist® Ephedrine Sulfate Injection, USP in a 25 mg per 5 mL (5 mg per mL) presentation. Fresenius Kabi Simplist® Ephedrine Sulfate Injection, USP in a 50 mg per 10 mL (5 mg per mL) ...
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive ...
The FDA approved a new 300 mg/2 mL dose of Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of four allergic and ...
The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, ...
The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback